Search

Matthew Radmer Phones & Addresses

  • 3524 Mcnair Ave, Minneapolis, MN 55422 (763) 521-4178
  • 3524 Mcnair Dr N, Minneapolis, MN 55422
  • 3608 Maryland Ave N, Minneapolis, MN 55427
  • Robbinsdale, MN
  • Minnetonka, MN

Interests

job inquiries, expertise requests, busin...

Industries

Chemicals

Resumes

Resumes

Matthew Radmer Photo 1

Formulation Chemist At Mgk

Location:
Greater Minneapolis-St. Paul Area
Industry:
Chemicals
Experience:
MGK (Privately Held; Chemicals industry): Formulation Chemist,  (May 2007-Present) Responsible for the development of novel formulations in the area of insect control. Skills utilized include aerosol development, analytical characterization (GC, LC, LC-MS), and advanced formulat...

Publications

Us Patents

Thioether Substituted Imidazoquinolines

US Patent:
6667312, Dec 23, 2003
Filed:
Jun 7, 2002
Appl. No.:
10/165222
Inventors:
Jason D. Bonk - Centerville MN
Joseph F. Dellaria - Woodbury MN
Bryon A. Merrill - River Falls WI
Matthew R. Radmer - Robbinsdale MN
Assignee:
3M Innovative Properties Company - St. Paul MN
International Classification:
A61K 314745
US Classification:
514274, 546 82, 546 84, 546159, 544316, 514293
Abstract:
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Ether Substituted Imidazopyridines

US Patent:
6797718, Sep 28, 2004
Filed:
Jun 6, 2003
Appl. No.:
10/456308
Inventors:
Joseph F. Dellaria - Woodbury MN
Kyle J. Lindstrom - Houlton WI
Luke T. Dressel - Somerset WI
Philip D. Heppner - Forest Lake MN
John R. Jacobsen - Woodbury MN
Matthew R. Radmer - Robbinsdale MN
Doris Stoermer - White Bear Lake MN
Assignee:
3M Innovative Properties Company - St. Paul MN
International Classification:
A61K 31437
US Classification:
514303, 546118, 544127, 544333, 5142342, 514256
Abstract:
Imidazopyridine compounds that contain an ether or thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

Thioether Substituted Imidazoquinolines

US Patent:
6921826, Jul 26, 2005
Filed:
Oct 29, 2003
Appl. No.:
10/696684
Inventors:
Joseph F. Dellaria - Woodbury MN, US
Bryon A. Merrill - River Falls WI, US
Matthew R. Radmer - Robbinsdale MN, US
Assignee:
3M Innovative Properties Co. - St. Paul MN
International Classification:
C07D471/04
A61K031/4745
A61P037/02
US Classification:
546 82, 546 84, 546159, 514293
Abstract:
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Thioether Substituted Imidazoquinolines

US Patent:
6949649, Sep 27, 2005
Filed:
Oct 29, 2003
Appl. No.:
10/696477
Inventors:
Jason D. Bonk - Centerville MN, US
Joseph F. Dellaria - Woodbury MN, US
Bryon A. Merrill - River Falls WI, US
Matthew R. Radmer - Robbinsdale MN, US
Assignee:
3M Innovative Properties Co. - St. Paul MN
International Classification:
C07D471/04
A61K031/4745
A61P037/02
US Classification:
546 82, 546 84, 544316, 514293, 514274
Abstract:
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Ether Substituted Imidazopyridines

US Patent:
7125890, Oct 24, 2006
Filed:
Aug 11, 2004
Appl. No.:
10/916125
Inventors:
Joseph F. Dellaria - Woodbury MN, US
Kyle J. Lindstrom - Houlton WI, US
Luke T. Dressel - Somerset WI, US
Daniel E. Duffy - White Bear Lake Township MN, US
Philip D. Heppner - Forest Lake MN, US
John R. Jacobsen - Woodbury MN, US
Joan T. Moseman - Lake Elmo MN, US
William H. Moser - St. Paul MN, US
Matthew R. Radmer - Robbinsdale MN, US
Doris Stoermer - White Bear Lake MN, US
Bernhard M. Zimmermann - Eagan MN, US
Assignee:
3M Innovative Properties Company - St. Paul MN
International Classification:
A61K 31/437
C07D 471/04
US Classification:
514303, 546118, 544127, 5142342
Abstract:
Imidazopyridine compounds that contain an ether or thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

Ether Substituted Imidazopyridines

US Patent:
7220758, May 22, 2007
Filed:
Jul 24, 2006
Appl. No.:
11/459489
Inventors:
Joseph F. Dellaria - Woodbury MN, US
Kyle J. Lindstrom - Houlton WI, US
Luke T. Dressel - Somerset WI, US
Philip D. Heppner - Forest Lake MN, US
John R. Jacobsen - Woodbury MN, US
Joan T. Moseman - Lake Elmo MN, US
William H. Moser - St. Paul MN, US
Matthew R. Radmer - Robbinsdale MN, US
Doris Stoermer - White Bear Lake MN, US
Assignee:
3M Innovative Properties Company - St. Paul MN
International Classification:
A61K 31/437
C07D 471/04
US Classification:
514303, 546118, 544127, 544333, 5142342, 514256
Abstract:
Imidazopyridine compounds that contain an ether or thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

Thioether Substituted Imidazoquinolines

US Patent:
7276515, Oct 2, 2007
Filed:
May 19, 2005
Appl. No.:
11/133425
Inventors:
Joseph F. Dellaria - Woodbury MN, US
Matthew R. Radmer - Robbinsdale MN, US
Assignee:
Coley Pharmaceutical Group, Inc. - Wellesley MA
International Classification:
A61K 31/44
C07D 471/04
US Classification:
514293, 546 82
Abstract:
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Thioether Substituted Imidazoquinolines

US Patent:
7288550, Oct 30, 2007
Filed:
May 19, 2005
Appl. No.:
11/132537
Inventors:
Joseph F. Dellaria - Woodbury MN, US
Matthew R. Radmer - Robbinsdale MN, US
Bryon A. Merrill - River Falls WI, US
Assignee:
3M Innovative Properties Company - St. Paul MN
International Classification:
A61K 31/4353
C07D 471/04
US Classification:
514293, 546 82
Abstract:
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
Matthew R Radmer from Robbinsdale, MN, age ~47 Get Report